Literature DB >> 7695632

Modulation of estradiol and DNA binding to estrogen receptor upon association with calmodulin.

A Bouhoute1, G Leclercq.   

Abstract

The ability of calmodulin (CaM) to modify the conformation of the hormone binding domain (HBD) rat uterine estrogen receptor (ER) was investigated. Dissociation constant of estradiol (E2) binding to HBD increased almost 2-3-fold when CaM bound to ER; two other Ca(++)-binding proteins failed to show this property, demonstrating the specificity of the phenomenon. Elution on CaM-Sepharose of truncated ER molecules located the CaM binding domain of ER at the left edge of HBD. Association of CaM with activated [3H]E2-ER complexes increased the ability of the latter to interact with an estrogen response element (ERE) as demonstrated by DNA-cellulose competition assay; CaM also reinforces the potency of ERE to dissociate the [3H]E2-ER complex. We hypothesize that these CaM-induced conformational changes of ER may play a role in transcriptional activity of the latter.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7695632     DOI: 10.1006/bbrc.1995.1401

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Structural basis for Ca2+-induced activation and dimerization of estrogen receptor α by calmodulin.

Authors:  Yonghong Zhang; Zhigang Li; David B Sacks; James B Ames
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

2.  Role of Ca2+ activation and bilobal structure of calmodulin in nuclear and nucleolar localization.

Authors:  Richard Thorogate; Katalin Török
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

3.  The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells.

Authors:  Rosamaria Lappano; Christophe Mallet; Bruno Rizzuti; Fedora Grande; Giulia Raffaella Galli; Cillian Byrne; Isabelle Broutin; Ludivine Boudieu; Alain Eschalier; Yves Jacquot; Marcello Maggiolini
Journal:  Cells       Date:  2019-06-14       Impact factor: 6.600

4.  Interaction of the Anti-Proliferative GPER Inverse Agonist ERα17p with the Breast Cancer Cell Plasma Membrane: From Biophysics to Biology.

Authors:  Michaël Trichet; Rosamaria Lappano; Mathilde Belnou; Lilian Shadai Salazar Vazquez; Isabel Alves; Delphine Ravault; Sandrine Sagan; Lucie Khemtemourian; Marcello Maggiolini; Yves Jacquot
Journal:  Cells       Date:  2020-02-15       Impact factor: 6.600

Review 5.  Reciprocality Between Estrogen Biology and Calcium Signaling in the Cardiovascular System.

Authors:  Quang-Kim Tran
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-29       Impact factor: 5.555

6.  The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice.

Authors:  Christophe Mallet; Ludivine Boudieu; Sylvain Lamoine; Catherine Coudert; Yves Jacquot; Alain Eschalier
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-17       Impact factor: 5.555

Review 7.  Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention.

Authors:  Ting Huang; Jingyi Zhou; Jianliu Wang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 8.  The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature.

Authors:  Anna Hagström; Ruba Kal Omar; Pete A Williams; Gustav Stålhammar
Journal:  BMC Cancer       Date:  2022-04-13       Impact factor: 4.430

9.  Regulatory function of the P295-T311 motif of the estrogen receptor alpha - does proteasomal degradation of the receptor induce emergence of peptides implicated in estrogenic responses?

Authors:  Dominique Gallo; Iman Haddad; Guy Laurent; Joëlle Vinh; Françoise Jacquemotte; Yves Jacquot; Guy Leclercq
Journal:  Nucl Recept Signal       Date:  2008-04-18

10.  Biosensor-based approach identifies four distinct calmodulin-binding domains in the G protein-coupled estrogen receptor 1.

Authors:  Quang-Kim Tran; Mark Vermeer
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.